PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,684,208 | -21.2% | 743,873 | +0.0% | 0.00% | -20.0% |
| Q2 2023 | $9,748,427 | +20.2% | 743,587 | +2.5% | 0.01% | +25.0% |
| Q1 2023 | $8,111,442 | +32.7% | 725,532 | +0.1% | 0.00% | +33.3% |
| Q4 2022 | $6,110,705 | -49.6% | 724,876 | -0.4% | 0.00% | -57.1% |
| Q3 2022 | $12,130,000 | +29.0% | 728,057 | +14.0% | 0.01% | +40.0% |
| Q2 2022 | $9,402,000 | -30.6% | 638,727 | +17.0% | 0.01% | 0.0% |
| Q1 2022 | $13,539,000 | +1.1% | 545,711 | +30.7% | 0.01% | 0.0% |
| Q4 2021 | $13,388,000 | -11.3% | 417,457 | -0.4% | 0.01% | -16.7% |
| Q3 2021 | $15,086,000 | -19.0% | 419,290 | -0.6% | 0.01% | -14.3% |
| Q2 2021 | $18,616,000 | +90.1% | 421,947 | +97.1% | 0.01% | +75.0% |
| Q1 2021 | $9,793,000 | -33.6% | 214,101 | +0.2% | 0.00% | -33.3% |
| Q4 2020 | $14,747,000 | – | 213,665 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |